EP2431355A4 - NOVEL VI-CRYSTALLINE FORM OF AGOMÉLATINE ITS PREPARATION METHOD AND APPLICATION - Google Patents

NOVEL VI-CRYSTALLINE FORM OF AGOMÉLATINE ITS PREPARATION METHOD AND APPLICATION

Info

Publication number
EP2431355A4
EP2431355A4 EP10750350A EP10750350A EP2431355A4 EP 2431355 A4 EP2431355 A4 EP 2431355A4 EP 10750350 A EP10750350 A EP 10750350A EP 10750350 A EP10750350 A EP 10750350A EP 2431355 A4 EP2431355 A4 EP 2431355A4
Authority
EP
European Patent Office
Prior art keywords
agomelatine
preparation
application
crystalline form
new crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10750350A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2431355A1 (en
Inventor
Hanbin Shan
Peng Zhang
Zhedong Yuan
Xudong Jiang
Yu Huang
Hubo Wang
Xufeng Cao
Xingdong Cheng
Xiong Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41370233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2431355(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of EP2431355A1 publication Critical patent/EP2431355A1/en
Publication of EP2431355A4 publication Critical patent/EP2431355A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Peptides Or Proteins (AREA)
EP10750350A 2009-03-10 2010-03-09 NOVEL VI-CRYSTALLINE FORM OF AGOMÉLATINE ITS PREPARATION METHOD AND APPLICATION Withdrawn EP2431355A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910047329.2A CN101585779B (zh) 2009-03-10 2009-03-10 阿戈美拉汀的晶型vi及其制备方法和应用
PCT/CN2010/070931 WO2010102554A1 (zh) 2009-03-10 2010-03-09 阿戈美拉汀的新晶型ⅵ及其制备方法和应用

Publications (2)

Publication Number Publication Date
EP2431355A1 EP2431355A1 (en) 2012-03-21
EP2431355A4 true EP2431355A4 (en) 2012-08-08

Family

ID=41370233

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10750350A Withdrawn EP2431355A4 (en) 2009-03-10 2010-03-09 NOVEL VI-CRYSTALLINE FORM OF AGOMÉLATINE ITS PREPARATION METHOD AND APPLICATION

Country Status (27)

Country Link
US (1) US8614251B2 (zh)
EP (1) EP2431355A4 (zh)
JP (1) JP2012519715A (zh)
KR (1) KR20110123266A (zh)
CN (1) CN101585779B (zh)
AP (1) AP3049A (zh)
AU (1) AU2010223720B2 (zh)
BR (1) BRPI1013249A2 (zh)
CA (1) CA2754276A1 (zh)
CL (1) CL2011002231A1 (zh)
CO (1) CO6410293A2 (zh)
CR (1) CR20110457A (zh)
CU (1) CU20110162A7 (zh)
EA (1) EA019127B1 (zh)
EC (1) ECSP11011309A (zh)
GE (1) GEP20146114B (zh)
HN (1) HN2011002408A (zh)
IL (1) IL214683A0 (zh)
MA (1) MA33100B1 (zh)
MX (1) MX2011009339A (zh)
NI (1) NI201100167A (zh)
PE (1) PE20120653A1 (zh)
SG (2) SG173692A1 (zh)
TN (1) TN2011000426A1 (zh)
UA (1) UA100476C2 (zh)
WO (1) WO2010102554A1 (zh)
ZA (1) ZA201106049B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101585779B (zh) 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
WO2011006387A1 (zh) * 2009-07-11 2011-01-20 浙江华海药业股份有限公司 阿戈美拉汀的制备方法、阿戈美拉汀晶形及其制备方法
CN101955440B (zh) * 2009-07-17 2014-04-09 江苏万特制药有限公司 一种阿戈美拉汀新晶型及其制备方法
CN102050756A (zh) * 2009-11-09 2011-05-11 北京利乐生制药科技有限公司 阿戈美拉汀新晶型及其制备方法
CN102190595A (zh) 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102557979B (zh) * 2010-12-16 2014-11-26 北大方正集团有限公司 一种阿戈美拉汀的晶型、其制备方法、用途及药物组合物
WO2012093402A1 (en) * 2011-01-04 2012-07-12 Symed Labs Limited Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
CN102690210A (zh) * 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的新晶型ⅶ、其制备方法、应用和包含其的药物组合物
CN102690209A (zh) * 2011-03-23 2012-09-26 上海医药工业研究院 阿戈美拉汀的混晶(形式-ⅷ)、其制备方法、应用和包含其的药物组合物
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2771312B1 (en) 2011-11-30 2017-05-31 ratiopharm GmbH Agomelatine-urea complex and crystalline forms thereof
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN103690499B (zh) * 2013-12-23 2015-05-06 天津泰普药品科技发展有限公司 一种稳定的晶i型阿戈美拉汀片剂及其制备方法
WO2015124496A1 (en) 2014-02-19 2015-08-27 Synthon B.V. Pharmaceutical composition comprising amorphous agomelatine
PL3075724T3 (pl) 2015-03-31 2023-12-27 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Stała postać agomelatyny

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182276A1 (en) * 2004-02-13 2005-08-18 Jean-Claude Souvie Process for the synthesis and crystalline form of agomelatine
EP1752444A1 (fr) * 2005-08-03 2007-02-14 Les Laboratoires Servier Nouvelle forme cristalline IV de l'Agomelatine, son procédé de preparation et les compositions pharmaceutiques qui la contiennent
EP2319827A1 (en) * 2009-11-09 2011-05-11 Ratiopharm GmbH Process for the production of polymorph form I of agomelatine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
FR2889523B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2889521B1 (fr) * 2005-08-03 2007-12-28 Servier Lab Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
FR2923482B1 (fr) * 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182276A1 (en) * 2004-02-13 2005-08-18 Jean-Claude Souvie Process for the synthesis and crystalline form of agomelatine
CN1680284A (zh) * 2004-02-13 2005-10-12 瑟维尔实验室 阿戈美拉汀的新合成方法、新晶型及其药物组合物
EP1752444A1 (fr) * 2005-08-03 2007-02-14 Les Laboratoires Servier Nouvelle forme cristalline IV de l'Agomelatine, son procédé de preparation et les compositions pharmaceutiques qui la contiennent
EP2319827A1 (en) * 2009-11-09 2011-05-11 Ratiopharm GmbH Process for the production of polymorph form I of agomelatine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010102554A1 *
TINANT B ET AL: "N-[2-(7-METHOXY-1-NAPHTHYL)ETHYL]-ACETAMIDE, A POTENT MELATONIN ANALOG", ACTA CRYSTALLOGRAPHICA SECTION C. CRYSTAL STRUCTURE COMMUNICATIONS, MUNKSGAARD, COPENHAGEN, DK, vol. C50, no. 6, 1 January 1994 (1994-01-01), pages 907 - 910, XP009047983, ISSN: 0108-2701, DOI: 10.1107/S0108270193012922 *
YOUS S ET AL: "NOVEL NAPHTHALENIC LIGANDS WITH HIGH AFFINITY FOR THE MELATIONIN RECEPTOR", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 35, no. 8, 17 April 1992 (1992-04-17), pages 1484 - 1486, XP002016145, ISSN: 0022-2623, DOI: 10.1021/JM00086A018 *

Also Published As

Publication number Publication date
EA201101304A1 (ru) 2012-04-30
CN101585779B (zh) 2014-04-02
EP2431355A1 (en) 2012-03-21
WO2010102554A1 (zh) 2010-09-16
KR20110123266A (ko) 2011-11-14
CO6410293A2 (es) 2012-03-30
AP2011005914A0 (en) 2011-10-31
CL2011002231A1 (es) 2012-02-03
BRPI1013249A2 (pt) 2016-04-05
SG177886A1 (en) 2012-02-28
AU2010223720B2 (en) 2012-05-03
CU20110162A7 (es) 2012-02-15
CN101585779A (zh) 2009-11-25
CR20110457A (es) 2011-09-21
SG173692A1 (en) 2011-09-29
IL214683A0 (en) 2011-11-30
US8614251B2 (en) 2013-12-24
ECSP11011309A (es) 2011-10-31
AP3049A (en) 2014-11-30
AU2010223720A1 (en) 2011-09-08
HN2011002408A (es) 2014-06-23
EA019127B1 (ru) 2014-01-30
UA100476C2 (en) 2012-12-25
TN2011000426A1 (en) 2013-03-27
MA33100B1 (fr) 2012-03-01
PE20120653A1 (es) 2012-06-14
GEP20146114B (en) 2014-07-10
JP2012519715A (ja) 2012-08-30
CA2754276A1 (en) 2010-09-16
MX2011009339A (es) 2011-09-27
US20120004313A1 (en) 2012-01-05
NI201100167A (es) 2012-01-11
ZA201106049B (en) 2012-10-31

Similar Documents

Publication Publication Date Title
AP3049A (en) New crystalline form VI of agomelatine, preparation method and application thereof
PL2058296T3 (pl) Nowa postać krystaliczna VI agomelatyny, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające
HK1164832A1 (zh) 含白皮杉醇組合物及含白皮杉醇組合物的製備方法
HRP20150072T1 (en) Agomelatine hydrohalide complex and preparation method thereof
EP2444398A4 (en) NEW INTERMEDIATE PRODUCTS FROM VORICONAZOLE AND PRODUCTION PROCESS FOR VORICONAZOLE THEREWITH
EP2582626A4 (en) UZM-35 ZEOLITHIC COMPOSITION, METHOD FOR PRODUCING THE SAME, AND METHODS
IL219913A0 (en) New process for the preparation of tapentadol and intermediates thereof
EP2394979A4 (en) INTERMEDIATE OF CILASTATIN AND METHOD FOR PREPARING THE SAME
HK1216986A1 (zh) 反式降舍曲林的製劑、鹽和晶體形式及其應用
EP2497766A4 (en) CRYSTALLINE FORM OF BIMATOPROST AND MANUFACTURING METHOD THEREFOR AND USE THEREOF
EP2573071A4 (en) PROCESS FOR THE PREPARATION OF (S) -4-HYDROXY-2-OXO-1-PYRROLIDINE ACETAMIDE
IL223180A0 (en) Agomelatine intermediates and preparation method thereof
EP2618844A4 (en) ORAL FORMABLE COMPOSITION AND METHOD FOR THEIR PRODUCTION AND USE
SI2151430T1 (sl) Nov postopek za pridobivanje kristalinične oblike V iz agomelatina
GB201210536D0 (en) Composition, use and method of preparation thereof
SI2376433T1 (sl) Kristalna oblika C tigeciklin dihidroklorida in postopki za njeno pripravo
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
GB201002278D0 (en) composition and method of preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110816

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA ME RS

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

A4 Supplementary search report drawn up and despatched

Effective date: 20120706

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/20 20060101ALI20120702BHEP

Ipc: A61P 25/22 20060101ALI20120702BHEP

Ipc: A61K 31/165 20060101ALI20120702BHEP

Ipc: A61P 25/18 20060101ALI20120702BHEP

Ipc: A61P 9/00 20060101ALI20120702BHEP

Ipc: A61P 5/00 20060101ALI20120702BHEP

Ipc: A61P 25/24 20060101ALI20120702BHEP

Ipc: C07C 233/18 20060101AFI20120702BHEP

Ipc: A61P 1/00 20060101ALI20120702BHEP

Ipc: A61P 25/00 20060101ALI20120702BHEP

17Q First examination report despatched

Effective date: 20130802

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131213